Chemotherapy with gemcitabine plus cisplatin in patients with advanced thymic squamous cell carcinoma: Evaluation of efficacy and toxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemotherapy with gemcitabine plus cisplatin in patients with advanced thymic squamous cell carcinoma: Evaluation of efficacy and toxicity

Published:2015-08-04 Issue:2 Volume:7 Page:167-172
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Luo Yang¹,Li Jun‐ling¹,Yang Lin²,Zhang Wen¹

Affiliation:

1. Department of Medical Oncology Cancer Institute/Hospital Peking Union Medical College & Chinese Academy of Medical Sciences Beijing China

2. Department of Pathology Cancer Institute/Hospital Peking Union Medical College & Chinese Academy of Medical Sciences Beijing China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.12300

Reference25 articles.

1. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan

2. Early Masaoka stage and complete resection is important for prognosis of thymic carcinoma: a 20-year experience at a single institution☆

3. Treatment and prognosis of thymic carcinoma

4. Platinum-based Chemotherapy with or without Thoracic Radiation Therapy in Patients with Unresectable Thymic Carcinoma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and outcome of systemic treatment for metastatic or unresectable thymic carcinoma: A single institution experience;Thoracic Cancer;2023-12-27

2. Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma;Investigational New Drugs;2023-01-12

3. Salvage Chemotherapy in Patients with Previously Treated Thymic Carcinoma;Cancers;2021-10-29

4. Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma;Thoracic Cancer;2018-11-09

5. Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study;The Oncologist;2018-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3